Hostname: page-component-cd9895bd7-dk4vv Total loading time: 0 Render date: 2024-12-25T05:37:20.276Z Has data issue: false hasContentIssue false

“How do you live without a stomach?”: A multiple case study examination of total gastrectomy for palliation or prophylaxis

Published online by Cambridge University Press:  15 August 2011

Sheila N. Garland*
Affiliation:
Department of Psychology, University of Calgary, Calgary, Alberta, Canada Department of Psychosocial Resources, Tom Baker Cancer Centre, Alberta Health Services, Calgary, Alberta, Canada
Joshua Lounsberry
Affiliation:
Department of Psychosocial Resources, Tom Baker Cancer Centre, Alberta Health Services, Calgary, Alberta, Canada
Guy Pelletier
Affiliation:
Department of Psychology, University of Calgary, Calgary, Alberta, Canada Department of Psychosocial Resources, Tom Baker Cancer Centre, Alberta Health Services, Calgary, Alberta, Canada Department of Oncology, University of Calgary, Calgary, Alberta, Canada
Oliver F. Bathe
Affiliation:
Department of Oncology, University of Calgary, Calgary, Alberta, Canada Department of Surgery, University of Calgary, Calgary, Alberta, Canada
*
Address correspondence and reprint requests to: Sheila N. Garland, Department of Psychology, University of Calgary, 2500 University Drive NW, Calgary, AB, Canada T2N 1N4. E-mail: [email protected]

Abstract

Objective:

The number of diagnosed cases of stomach cancer in Western countries is relatively small compared to prevalence rates in Eastern populations. This disparity creates a general lack of information and understanding of the experience of patients treated for this disease in North America. Surgical removal of the stomach, also called total gastrectomy (TG), is presently the only curative treatment available to patients with stomach cancer. Considering the impact such a procedure may have, very little is known about what factors influence an individual's postsurgical quality of life (QL).

Method:

This article reviews current literature and examines three unique case studies. Semi-structured interviews were analyzed using content analysis, a qualitative analytic approach for reporting combined subject responses.

Results:

Participants included one 37-year-old man with multiple polyps in his stomach and a family history of stomach cancer, one 18 year-old man with a confirmed CDH1 mutation and a family history of stomach cancer, and one 33-year-old man with confirmed metastatic gastric adenocarcinoma. Subjective patient experience was categorized into: (1) making the decision, (2) treatment impact, and (3) life after TG. Prior to surgery, all patients carefully evaluated their perceived risk compared to the treatment consequences and indicated that a certain event triggered their decision. The largest treatment impacts were learning to eat again and adjusting to the physical changes. Each patient endorsed that their experience made them appreciate and make the most of life.

Significance of results:

This currently represents the only study to investigate the lived experience of TG for prophylaxis or palliation in individuals with and without genetic risk for stomach cancer. Understanding this process will allow all members of the cancer care team, and the patients themselves, to better understand the factors involved in decision making and postoperative adjustment. Fruitful avenues for future research are discussed.

Type
Original Articles
Copyright
Copyright © Cambridge University Press 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

Avery, K., Hughes, R., McNair, A., et al. (2010). Health-related quality of life and survival in the 2 years after surgery for gastric cancer. European Journal of Surgical Oncolog : The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 36, 148154.Google Scholar
Blair, V., Martin, I., Shaw, D., et al. (2006). Hereditary diffuse gastric cancer: Diagnosis and management. Clinical Gastroenterology & Hepatology, 4, 262275.CrossRefGoogle ScholarPubMed
Briasoulis, E., Ziogas, D. & Fatouros, M. (2008). Prophylactic surgery in the complex decision-making management of BRCA mutation carriers. Annals of Surgical Oncology, 15, 17881792.Google Scholar
Cisco, R.M., Ford, J.M. & Norton, J.A. (2008). Hereditary diffuse gastric cancer: Implications of genetic testing for screening and prophylactic surgery. Cancer, 113(Suppl. 7), 18501856.Google Scholar
Conroy, T., Marchal, F. & Blazeby, J.M. (2006). Quality of life in patients with oesophageal and gastric cancer: An overview. Oncology, 70, 391402.Google Scholar
Dicken, B.J., Bigam, D.L., Cass, C., et al. (2005). Gastric adenocarcinoma: Review and considerations for future directions. Annals of Surgery, 241, 2739.Google Scholar
Garland, S.N., Pelletier, G., Lawe, A., et al. (2011). Prospective evaluation of the reliability, validity, and minimally important difference of the functional assessment of cancer therapy-gastric (FACT-Ga) quality of life instrument. Cancer: A Journal of the American Cancer Society, 117, 13021312.Google Scholar
Green, K.L., Cameron, R., Polivy, J., et al. (1997). Weight dissatisfaction and weight loss attempts among Canadian adults. Canadian heart health surveys research group. CMAJ: Canadian Medical Association Journal = Journal De l'Association Medicale Canadienne, 157(Suppl. 1), S17S25.Google Scholar
Hebbard, P.C., Macmillan, A., Huntsman, D., et al. (2009). Prophylactic total gastrectomy (PTG) for hereditary diffuse gastric cancer (HDGC): The newfoundland experience with 23 patients. Annals of Surgical Oncology, 16, 18901895.CrossRefGoogle ScholarPubMed
Hickey, G. & Kipping, C. (1996). A multi-stage approach to the coding of data from open-ended questions. Nurse Researcher, 4, 8191.Google Scholar
Hoover, D.J., Paragi, P.R., Santoro, E., et al. (2010). Prophylactic mastectomy in high risk patients: A practice-based review of the indications. Do we follow guidelines? Breast Disease, 31, 1927.Google Scholar
Jemal, A., Siegel, R., Ward, E., et al. (2009). Cancer statistics, 2009. CA: A Cancer Journal for Clinicians, 59, 225249.Google Scholar
Kaas, R., Verhoef, S., Wesseling, J., et al. (2010). Prophylactic mastectomy in BRCA1 and BRCA2 mutation carriers: Very low risk for subsequent breast cancer. Annals of Surgery, 251, 488492.CrossRefGoogle ScholarPubMed
Kim, S., Bae, J.M., Kim, Y.W., et al. (2008). Self-reported experience and outcomes of care among stomach cancer patients at a median follow-up time of 27 months from diagnosis. Supportive Care in Cancer, 16, 831839.Google Scholar
Krippendorff, K. (1980). Content Analysis: An Introduction to its Methodology. London: Sage.Google Scholar
Lee, V. (2008). The existential plight of cancer: Meaning making as a concrete approach to the intangible search for meaning. Supportive Care in Cancer, 16, 779785.Google Scholar
Lemon, S.C., Rosal, M.C., Zapka, J., et al. (2009). Contributions of weight perceptions to weight loss attempts: Differences by body mass index and gender. Body Image, 6, 9096.CrossRefGoogle ScholarPubMed
Lynch, H.T., Silva, E., Wirtzfeld, D., et al. (2008). Hereditary diffuse gastric cancer: Prophylactic surgical oncology implications. Surgical Clinics of North America, 88, 759778.CrossRefGoogle ScholarPubMed
McQuirter, M., Castiglia, L.L., Loiselle, C.G., et al. (2010). Decision-making process of women carrying a BRCA1 or BRCA2 mutation who have chosen prophylactic mastectomy. Oncology Nursing Forum, 37, 313320.Google Scholar
Mizoue, T., Yoshimura, T., Tokui, N., et al. (2003). Prospective study of screening for stomach cancer in japan. International Journal of Cancer. Journal International du Cancer, 106, 103107.Google Scholar
Norton, J.A., Ham, C.M., Van Dam, J., et al. (2007). CDH1 truncating mutations in the E-cadherin gene: An indication for total gastrectomy to treat hereditary diffuse gastric cancer. Annals of Surgery, 245, 873879.CrossRefGoogle ScholarPubMed
Parkin, D.M., Bray, F., Ferlay, J., et al. (2005). Global cancer statistics, 2002. CA: A Cancer Journal for Clinicians, 55, 74108.Google ScholarPubMed
Petersen, S., Heesacker, M., Schwartz, R.C., et al. (2000). Predictors of decision-making style among cancer patients: An empirical test of theory. Psychology & Health, 15, 663675.CrossRefGoogle Scholar
Rebbeck, T.R. (2000). Prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers. Journal of Clinical Oncology:Official Journal of the American Society of Clinical Oncology, 18(Suppl 21), 100S103S.Google Scholar
Rosen, B., Kwon, J., Fung Kee Fung, M., et al. (2004). Systematic review of management options for women with a hereditary predisposition to ovarian cancer. Gynecologic Oncology, 93, 280286.Google Scholar
Schwartz, M.D., Peshkin, B.N., Tercyak, K.P., et al. (2005). Decision making and decision support for hereditary breast–ovarian cancer susceptibility. Health Psychology:Official Journal of the Division of Health Psychology, American Psychological Association, 24 (Suppl. 4), S78S84.Google Scholar
Schwarz, A. (2003). Preventive gastrectomy in patients with gastric cancer risk due to genetic alterations of the E-cadherin gene defect. Langenbeck's Archives of Surgery/Deutsche Gesellschaft Fur Chirurgie, 388, 2732.Google Scholar
Spear, S.L., Carter, M.E. & Schwarz, K. (2005). Prophylactic mastectomy: Indications, options, and reconstructive alternatives. Plastic and Reconstructive Surgery, 115, 891909.Google Scholar
Tyrvainen, T., Sand, J., Sintonen, H., et al. (2008). Quality of life in the long-term survivors after total gastrectomy for gastric carcinoma. Journal of Surgical Oncology, 97, 121124.Google Scholar
Vickery, C.W., Blazeby, J.M., Conroy, T., et al. (2001). Development of an EORTC disease-specific quality of life module for use in patients with gastric cancer. European Journal of Cancer, 37, 966971.Google Scholar
Yellen, S.B. & Cella, D.F. (1995). Someone to live for: Social well-being, parenthood status, and decision-making in oncology. Journal of Clinical Oncology:Official Journal of the American Society of Clinical Oncology, 13, 12551264.CrossRefGoogle ScholarPubMed